Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Two Cycles of PAD Combination by AHCT in MM
- Status
- COMPLETED
- Phase
- PHASE2
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Unrelated Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
- Status
- COMPLETED
- Phase
- N/A
Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Redirected Auto T Cells for Advanced Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
- Status
- COMPLETED
- Phase
- PHASE2
Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Preservation of Ovarian Function After Hematopoietic Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE1
THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2